Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Carlisle Companies Expands with Plasti-Fab Acquisition — Oct 19th, 2024

https://www.tipranks.com/news/company-announcements/united-airlines-faces-uncertainty-in-share-repurchase-program-impacting-stockholder-value The latest update is out from Carlisle Companies ( (CSL) ). Carlisle Companies is set to expand its influence in the North American expanded polys...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies — Oct 21st, 2024

The Riverside Company CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement ...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

UK secures over 5 million H5 influenza vaccine doses as pandemic precaution — Dec 3rd, 2024

Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic....

Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock? — Oct 21st, 2024

Carlisle Companies' (NYSE:CSL) stock is up by a considerable 10% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particular...

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....

Teva hit with $503 mln EU antitrust fine for disparaging rival product — Oct 31st, 2024

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its blockbuster multiple sclerosis medicine Copaxone....